In patients with dry eye disease, Miebo before cataract surgery had no impact on the accuracy of preoperative measurements and predicted refractive error, according to a study published in Ophthalmology and Therapy.
Patients who received Miebo (perfluorohexyloctane ophthalmic solution, Bausch + Lomb) also had significant improvements in signs and symptoms of dry eye disease both before and after cataract surgery.
“We were excited to do this study because there had been a prior study looking at how perfluorohexyloctane would work in healthy eyes that had biometry, and it showed that it had no